BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12475773)

  • 1. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Pearson ER; Liddell WG; Shepherd M; Corrall RJ; Hattersley AT
    Diabet Med; 2000 Jul; 17(7):543-5. PubMed ID: 10972586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
    Pontoglio M; Sreenan S; Roe M; Pugh W; Ostrega D; Doyen A; Pick AJ; Baldwin A; Velho G; Froguel P; Levisetti M; Bonner-Weir S; Bell GI; Yaniv M; Polonsky KS
    J Clin Invest; 1998 May; 101(10):2215-22. PubMed ID: 9593777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells.
    Yang Q; Yamagata K; Fukui K; Cao Y; Nammo T; Iwahashi H; Wang H; Matsumura I; Hanafusa T; Bucala R; Wollheim CB; Miyagawa J; Matsuzawa Y
    Diabetes; 2002 Jun; 51(6):1785-92. PubMed ID: 12031966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism.
    Shih DQ; Screenan S; Munoz KN; Philipson L; Pontoglio M; Yaniv M; Polonsky KS; Stoffel M
    Diabetes; 2001 Nov; 50(11):2472-80. PubMed ID: 11679424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
    Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
    Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3).
    Guenat E; Seematter G; Philippe J; Temler E; Jéquier E; Tappy L
    Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.
    Okita K; Yang Q; Yamagata K; Hangenfeldt KA; Miyagawa J; Kajimoto Y; Nakajima H; Namba M; Wollheim CB; Hanafusa T; Matsuzawa Y
    Biochem Biophys Res Commun; 1999 Sep; 263(2):566-9. PubMed ID: 10491332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
    Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
    Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific reactivation of the inactivated Hnf-1alpha gene: elimination of liver dysfunction to establish a mouse MODY3 model.
    Lee YH; Magnuson MA; Muppala V; Chen SS
    Mol Cell Biol; 2003 Feb; 23(3):923-32. PubMed ID: 12529398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNF-1alpha and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity.
    Divine JK; McCaul SP; Simon TC
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G62-72. PubMed ID: 12646418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
    Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
    EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.